tirzepatide oral drops vs injection Compounded Tirzepatide: Vs. Injectable Forms Compound Tirzepatide

SGLT2i are the first class of antidiabetics with widely proven clinical benefits on HF prognosis ( 4.2 Heart failure drugs According to the current guidelines of ECS ( The standard 1st line therapy for HF includes quadruple combination of SGLT2 inhibitor, ACEi (angiotensin converting enzyme inhibitor)/ARNI (angiotensin receptorneprilysin inhibitor), betablocker and MRA (mineralocorticoid receptor antagonist)

This program includes: Initial exam 4-8 weeks of physician monitored medication (Phentermine)* Diet plan Activity/exercise plan Counseling Weekly visits and weigh-ins *Program does not include the medications, but includes monitoring

Glucagon-Like peptide 1 receptor agonist ZP10A increases insulin mRNA expression and prevents diabetic progression in db/db mice // J

We look forward to working with you on a referral or co-counsel basis